APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

NK Cell Cytotoxicity Assay Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NK Cell Cytotoxicity Assay Service Market Outlook and Growth Opportunities 2026

Report ID 174455060412 August 2026202 pages

Choose your research edition.

Industry ResearchNK Cell Cytotoxicity Assay Service Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NK Cell Cytotoxicity Assay Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal NK Cell Cytotoxicity Assay Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK Cell Cytotoxicity Assay Service Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal NK Cell Cytotoxicity Assay Service Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global NK Cell Cytotoxicity Assay Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NK Cell Cytotoxicity Assay Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NK Cell Cytotoxicity Assay Service market include Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology, ProBio, Charles River, Imodels and Xeno Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global NK Cell Cytotoxicity Assay Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NK Cell Cytotoxicity Assay Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NK Cell Cytotoxicity Assay Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global NK Cell Cytotoxicity Assay Service market.

NK Cell Cytotoxicity Assay Service Segment by Company

Reaction Biology

Axion BioSystems

Sartorius

ICE Bioscience

Shanghai Saily Biotechnology

ProBio

Charles River

Imodels

Xeno Diagnostics

Cyagen

MarinBio

Pharmalegacy

Celentyx

Crown Bioscience

Cellomatics Biosciences

Agilent

Laboratories

Explicyte

NK Cell Cytotoxicity Assay Service Segment by Type

LDH (Lactate Dehydrogenase) Release Method

51Cr Release Method

Flow Cytometry Detection

Other

NK Cell Cytotoxicity Assay Service Segment by Application

Cancer Research

Infectious Disease Research

Immunotherapy Development

NK Cell Cytotoxicity Assay Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NK Cell Cytotoxicity Assay Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the NK Cell Cytotoxicity Assay Service key companies, revenue, market share, and recent developments.

3. To split the NK Cell Cytotoxicity Assay Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions NK Cell Cytotoxicity Assay Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NK Cell Cytotoxicity Assay Service significant trends, drivers, influence factors in global and regions.

6. To analyze NK Cell Cytotoxicity Assay Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Cytotoxicity Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cell Cytotoxicity Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Cytotoxicity Assay Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NK Cell Cytotoxicity Assay Service industry.

Chapter 3: Detailed analysis of NK Cell Cytotoxicity Assay Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of NK Cell Cytotoxicity Assay Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of NK Cell Cytotoxicity Assay Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NK Cell Cytotoxicity Assay Service Industry Trends Table 2. NK Cell Cytotoxicity Assay Service Industry Drivers Table 3. NK Cell Cytotoxicity Assay Service Industry Opportunities and Challenges Table 4. NK Cell Cytotoxicity Assay Service Industry Restraints Table 5. Global NK Cell Cytotoxicity Assay Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NK Cell Cytotoxicity Assay Service Revenue Share by Company (2021-2026) Table 7. Global NK Cell Cytotoxicity Assay Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global NK Cell Cytotoxicity Assay Service Key Company Manufacturing Base & Headquarters Table 9. Global NK Cell Cytotoxicity Assay Service Company, Product Type & Application Table 10. Global NK Cell Cytotoxicity Assay Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global NK Cell Cytotoxicity Assay Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of LDH (Lactate Dehydrogenase) Release Method Table 15. Significant Companies of 51Cr Release Method Table 16. Significant Companies of Flow Cytometry Detection Table 17. Significant Companies of Other Table 18. Global NK Cell Cytotoxicity Assay Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global NK Cell Cytotoxicity Assay Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global NK Cell Cytotoxicity Assay Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Type (2021-2026) Table 22. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Cancer Research Table 24. Significant Companies of Infectious Disease Research Table 25. Significant Companies of Immunotherapy Development Table 26. Global NK Cell Cytotoxicity Assay Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global NK Cell Cytotoxicity Assay Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global NK Cell Cytotoxicity Assay Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Application (2021-2026) Table 30. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Application (2027-2032) Table 31. Global NK Cell Cytotoxicity Assay Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global NK Cell Cytotoxicity Assay Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Region (2021-2026) Table 34. Global NK Cell Cytotoxicity Assay Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Region (2027-2032) Table 36. Global NK Cell Cytotoxicity Assay Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global NK Cell Cytotoxicity Assay Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global NK Cell Cytotoxicity Assay Service Sales Value Market Share by Country (2021-2026) Table 39. Global NK Cell Cytotoxicity Assay Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global NK Cell Cytotoxicity Assay Service Sales Value Market Share by Country (2027-2032) Table 41. Reaction Biology Company Information Table 42. Reaction Biology Business Overview Table 43. Reaction Biology NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Reaction Biology NK Cell Cytotoxicity Assay Service Product Portfolio Table 45. Reaction Biology Recent Development Table 46. Axion BioSystems Company Information Table 47. Axion BioSystems Business Overview Table 48. Axion BioSystems NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Axion BioSystems NK Cell Cytotoxicity Assay Service Product Portfolio Table 50. Axion BioSystems Recent Development Table 51. Sartorius Company Information Table 52. Sartorius Business Overview Table 53. Sartorius NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Sartorius NK Cell Cytotoxicity Assay Service Product Portfolio Table 55. Sartorius Recent Development Table 56. ICE Bioscience Company Information Table 57. ICE Bioscience Business Overview Table 58. ICE Bioscience NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. ICE Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio Table 60. ICE Bioscience Recent Development Table 61. Shanghai Saily Biotechnology Company Information Table 62. Shanghai Saily Biotechnology Business Overview Table 63. Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Product Portfolio Table 65. Shanghai Saily Biotechnology Recent Development Table 66. ProBio Company Information Table 67. ProBio Business Overview Table 68. ProBio NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. ProBio NK Cell Cytotoxicity Assay Service Product Portfolio Table 70. ProBio Recent Development Table 71. Charles River Company Information Table 72. Charles River Business Overview Table 73. Charles River NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Charles River NK Cell Cytotoxicity Assay Service Product Portfolio Table 75. Charles River Recent Development Table 76. Imodels Company Information Table 77. Imodels Business Overview Table 78. Imodels NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Imodels NK Cell Cytotoxicity Assay Service Product Portfolio Table 80. Imodels Recent Development Table 81. Xeno Diagnostics Company Information Table 82. Xeno Diagnostics Business Overview Table 83. Xeno Diagnostics NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Xeno Diagnostics NK Cell Cytotoxicity Assay Service Product Portfolio Table 85. Xeno Diagnostics Recent Development Table 86. Cyagen Company Information Table 87. Cyagen Business Overview Table 88. Cyagen NK Cell Cytotoxicity Assay Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Cyagen NK Cell Cytotoxicity Assay Service Product Portfolio Table 90. Cyagen Recent Development Table 91. MarinBio Company Information Table 92. MarinBio Business Overview Table 93. MarinBio NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. MarinBio NK Cell Cytotoxicity Assay Service Product Portfolio Table 95. MarinBio Recent Development Table 96. Pharmalegacy Company Information Table 97. Pharmalegacy Business Overview Table 98. Pharmalegacy NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Pharmalegacy NK Cell Cytotoxicity Assay Service Product Portfolio Table 100. Pharmalegacy Recent Development Table 101. Celentyx Company Information Table 102. Celentyx Business Overview Table 103. Celentyx NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Celentyx NK Cell Cytotoxicity Assay Service Product Portfolio Table 105. Celentyx Recent Development Table 106. Crown Bioscience Company Information Table 107. Crown Bioscience Business Overview Table 108. Crown Bioscience NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Crown Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio Table 110. Crown Bioscience Recent Development Table 111. Cellomatics Biosciences Company Information Table 112. Cellomatics Biosciences Business Overview Table 113. Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Product Portfolio Table 115. Cellomatics Biosciences Recent Development Table 116. Agilent Company Information Table 117. Agilent Business Overview Table 118. Agilent NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Agilent NK Cell Cytotoxicity Assay Service Product Portfolio Table 120. Agilent Recent Development Table 121. Laboratories Company Information Table 122. Laboratories Business Overview Table 123. Laboratories NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Laboratories NK Cell Cytotoxicity Assay Service Product Portfolio Table 125. Laboratories Recent Development Table 126. Explicyte Company Information Table 127. Explicyte Business Overview Table 128. Explicyte NK Cell Cytotoxicity Assay Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Explicyte NK Cell Cytotoxicity Assay Service Product Portfolio Table 130. Explicyte Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. NK Cell Cytotoxicity Assay Service Product Image Figure 2. Global NK Cell Cytotoxicity Assay Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 4. Global NK Cell Cytotoxicity Assay Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. LDH (Lactate Dehydrogenase) Release Method Image Figure 8. 51Cr Release Method Image Figure 9. Flow Cytometry Detection Image Figure 10. Other Image Figure 11. Global NK Cell Cytotoxicity Assay Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global NK Cell Cytotoxicity Assay Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Type (2021-2032) Figure 14. Cancer Research Image Figure 15. Infectious Disease Research Image Figure 16. Immunotherapy Development Image Figure 17. Global NK Cell Cytotoxicity Assay Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global NK Cell Cytotoxicity Assay Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Application (2021-2032) Figure 20. Global NK Cell Cytotoxicity Assay Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global NK Cell Cytotoxicity Assay Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America NK Cell Cytotoxicity Assay Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America NK Cell Cytotoxicity Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe NK Cell Cytotoxicity Assay Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe NK Cell Cytotoxicity Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific NK Cell Cytotoxicity Assay Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific NK Cell Cytotoxicity Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America NK Cell Cytotoxicity Assay Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America NK Cell Cytotoxicity Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa NK Cell Cytotoxicity Assay Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa NK Cell Cytotoxicity Assay Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • LDH (Lactate Dehydrogenase) Release Method
  • 51Cr Release Method
  • Flow Cytometry Detection
  • Other
Applications
  • Cancer Research
  • Infectious Disease Research
  • Immunotherapy Development
Companies covered
  • Reaction Biology
  • Axion BioSystems
  • Sartorius
  • ICE Bioscience
  • Shanghai Saily Biotechnology
  • ProBio
  • Charles River
  • Imodels
  • Xeno Diagnostics
  • Cyagen
  • MarinBio
  • Pharmalegacy
  • Celentyx
  • Crown Bioscience
  • Cellomatics Biosciences
  • Agilent
  • Laboratories
  • Explicyte

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NK Cell Cytotoxicity Assay Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NK Cell Cytotoxicity Assay Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 NK Cell Cytotoxicity Assay Service Market Dynamics
  1. 2.1 NK Cell Cytotoxicity Assay Service Industry Trends
  2. 2.2 NK Cell Cytotoxicity Assay Service Industry Drivers
  3. 2.3 NK Cell Cytotoxicity Assay Service Industry Opportunities and Challenges
  4. 2.4 NK Cell Cytotoxicity Assay Service Industry Restraints
3 NK Cell Cytotoxicity Assay Service Market by Company
  1. 3.1 Global NK Cell Cytotoxicity Assay Service Company Revenue Ranking in 2025
  2. 3.2 Global NK Cell Cytotoxicity Assay Service Revenue by Company (2021-2026)
  3. 3.3 Global NK Cell Cytotoxicity Assay Service Company Ranking (2024-2026)
  4. 3.4 Global NK Cell Cytotoxicity Assay Service Company Manufacturing Base and Headquarters
  5. 3.5 Global NK Cell Cytotoxicity Assay Service Company Product Type and Application
  6. 3.6 Global NK Cell Cytotoxicity Assay Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global NK Cell Cytotoxicity Assay Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 NK Cell Cytotoxicity Assay Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 NK Cell Cytotoxicity Assay Service Market by Type
  1. 4.1 NK Cell Cytotoxicity Assay Service Type Introduction
  2. 4.1.1 LDH (Lactate Dehydrogenase) Release Method
  3. 4.1.2 51Cr Release Method
  4. 4.1.3 Flow Cytometry Detection
  5. 4.1.4 Other
  6. 4.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Type
  7. 4.2.1 Global NK Cell Cytotoxicity Assay Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global NK Cell Cytotoxicity Assay Service Sales Value Share by Type (2021-2032)
5 NK Cell Cytotoxicity Assay Service Market by Application
  1. 5.1 NK Cell Cytotoxicity Assay Service Application Introduction
  2. 5.1.1 Cancer Research
  3. 5.1.2 Infectious Disease Research
  4. 5.1.3 Immunotherapy Development
  5. 5.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Application
  6. 5.2.1 Global NK Cell Cytotoxicity Assay Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global NK Cell Cytotoxicity Assay Service Sales Value Share by Application (2021-2032)
6 NK Cell Cytotoxicity Assay Service Regional Value Analysis
  1. 6.1 Global NK Cell Cytotoxicity Assay Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global NK Cell Cytotoxicity Assay Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NK Cell Cytotoxicity Assay Service Sales Value (2021-2032)
  7. 6.3.2 North America NK Cell Cytotoxicity Assay Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe NK Cell Cytotoxicity Assay Service Sales Value (2021-2032)
  10. 6.4.2 Europe NK Cell Cytotoxicity Assay Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific NK Cell Cytotoxicity Assay Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific NK Cell Cytotoxicity Assay Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America NK Cell Cytotoxicity Assay Service Sales Value (2021-2032)
  16. 6.6.2 South America NK Cell Cytotoxicity Assay Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa NK Cell Cytotoxicity Assay Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa NK Cell Cytotoxicity Assay Service Sales Value Share by Country, 2025 VS 2032
7 NK Cell Cytotoxicity Assay Service Country-level Value Analysis
  1. 7.1 Global NK Cell Cytotoxicity Assay Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global NK Cell Cytotoxicity Assay Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global NK Cell Cytotoxicity Assay Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt NK Cell Cytotoxicity Assay Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt NK Cell Cytotoxicity Assay Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt NK Cell Cytotoxicity Assay Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Reaction Biology
  2. 8.1.1 Reaction Biology Company Information
  3. 8.1.2 Reaction Biology Business Overview
  4. 8.1.3 Reaction Biology NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Reaction Biology NK Cell Cytotoxicity Assay Service Product Portfolio
  6. 8.1.5 Reaction Biology Recent Developments
  7. 8.2 Axion BioSystems
  8. 8.2.1 Axion BioSystems Company Information
  9. 8.2.2 Axion BioSystems Business Overview
  10. 8.2.3 Axion BioSystems NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Axion BioSystems NK Cell Cytotoxicity Assay Service Product Portfolio
  12. 8.2.5 Axion BioSystems Recent Developments
  13. 8.3 Sartorius
  14. 8.3.1 Sartorius Company Information
  15. 8.3.2 Sartorius Business Overview
  16. 8.3.3 Sartorius NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sartorius NK Cell Cytotoxicity Assay Service Product Portfolio
  18. 8.3.5 Sartorius Recent Developments
  19. 8.4 ICE Bioscience
  20. 8.4.1 ICE Bioscience Company Information
  21. 8.4.2 ICE Bioscience Business Overview
  22. 8.4.3 ICE Bioscience NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ICE Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio
  24. 8.4.5 ICE Bioscience Recent Developments
  25. 8.5 Shanghai Saily Biotechnology
  26. 8.5.1 Shanghai Saily Biotechnology Company Information
  27. 8.5.2 Shanghai Saily Biotechnology Business Overview
  28. 8.5.3 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Product Portfolio
  30. 8.5.5 Shanghai Saily Biotechnology Recent Developments
  31. 8.6 ProBio
  32. 8.6.1 ProBio Company Information
  33. 8.6.2 ProBio Business Overview
  34. 8.6.3 ProBio NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ProBio NK Cell Cytotoxicity Assay Service Product Portfolio
  36. 8.6.5 ProBio Recent Developments
  37. 8.7 Charles River
  38. 8.7.1 Charles River Company Information
  39. 8.7.2 Charles River Business Overview
  40. 8.7.3 Charles River NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Charles River NK Cell Cytotoxicity Assay Service Product Portfolio
  42. 8.7.5 Charles River Recent Developments
  43. 8.8 Imodels
  44. 8.8.1 Imodels Company Information
  45. 8.8.2 Imodels Business Overview
  46. 8.8.3 Imodels NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Imodels NK Cell Cytotoxicity Assay Service Product Portfolio
  48. 8.8.5 Imodels Recent Developments
  49. 8.9 Xeno Diagnostics
  50. 8.9.1 Xeno Diagnostics Company Information
  51. 8.9.2 Xeno Diagnostics Business Overview
  52. 8.9.3 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Product Portfolio
  54. 8.9.5 Xeno Diagnostics Recent Developments
  55. 8.10 Cyagen
  56. 8.10.1 Cyagen Company Information
  57. 8.10.2 Cyagen Business Overview
  58. 8.10.3 Cyagen NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cyagen NK Cell Cytotoxicity Assay Service Product Portfolio
  60. 8.10.5 Cyagen Recent Developments
  61. 8.11 MarinBio
  62. 8.11.1 MarinBio Company Information
  63. 8.11.2 MarinBio Business Overview
  64. 8.11.3 MarinBio NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MarinBio NK Cell Cytotoxicity Assay Service Product Portfolio
  66. 8.11.5 MarinBio Recent Developments
  67. 8.12 Pharmalegacy
  68. 8.12.1 Pharmalegacy Company Information
  69. 8.12.2 Pharmalegacy Business Overview
  70. 8.12.3 Pharmalegacy NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pharmalegacy NK Cell Cytotoxicity Assay Service Product Portfolio
  72. 8.12.5 Pharmalegacy Recent Developments
  73. 8.13 Celentyx
  74. 8.13.1 Celentyx Company Information
  75. 8.13.2 Celentyx Business Overview
  76. 8.13.3 Celentyx NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Celentyx NK Cell Cytotoxicity Assay Service Product Portfolio
  78. 8.13.5 Celentyx Recent Developments
  79. 8.14 Crown Bioscience
  80. 8.14.1 Crown Bioscience Company Information
  81. 8.14.2 Crown Bioscience Business Overview
  82. 8.14.3 Crown Bioscience NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Crown Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio
  84. 8.14.5 Crown Bioscience Recent Developments
  85. 8.15 Cellomatics Biosciences
  86. 8.15.1 Cellomatics Biosciences Company Information
  87. 8.15.2 Cellomatics Biosciences Business Overview
  88. 8.15.3 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Product Portfolio
  90. 8.15.5 Cellomatics Biosciences Recent Developments
  91. 8.16 Agilent
  92. 8.16.1 Agilent Company Information
  93. 8.16.2 Agilent Business Overview
  94. 8.16.3 Agilent NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Agilent NK Cell Cytotoxicity Assay Service Product Portfolio
  96. 8.16.5 Agilent Recent Developments
  97. 8.17 Laboratories
  98. 8.17.1 Laboratories Company Information
  99. 8.17.2 Laboratories Business Overview
  100. 8.17.3 Laboratories NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Laboratories NK Cell Cytotoxicity Assay Service Product Portfolio
  102. 8.17.5 Laboratories Recent Developments
  103. 8.18 Explicyte
  104. 8.18.1 Explicyte Company Information
  105. 8.18.2 Explicyte Business Overview
  106. 8.18.3 Explicyte NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Explicyte NK Cell Cytotoxicity Assay Service Product Portfolio
  108. 8.18.5 Explicyte Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst